adipose-derived stem/stromal cells (AD-cSVF) / Bimini Health Tech - LARVOL DELTA

cSVF-Lung: Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD) (clinicaltrials.gov) - P1 | N=50 | Suspended | Sponsor: Healeon Medical Inc | Trial completion date: Sep 2025 ➔ Sep 2026 | Trial primary completion date: Apr 2024 ➔ Sep 2025

Trial completion date • Trial primary completion date • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases

GARM-MS: Use of Stromal Vascular Fraction in Multiple Sclerosis (clinicaltrials.gov) - P=N/A | N=100 | Suspended | Sponsor: Healeon Medical Inc | Trial completion date: Dec 2024 ➔ Dec 2026 | Trial primary completion date: Jan 2024 ➔ Jan 2025

Trial completion date • Trial primary completion date • CNS Disorders • Immunology • Multiple Sclerosis

ADcSVF-IBD: Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease (clinicaltrials.gov) - P1/2 | N=100 | Suspended | Sponsor: Healeon Medical Inc | Trial completion date: Jun 2025 ➔ Sep 2026 | Enrolling by invitation ➔ Suspended | Trial primary completion date: Aug 2024 ➔ Sep 2025

Trial completion date • Trial primary completion date • Trial suspension • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease

ADcSVF-COPD: Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders (clinicaltrials.gov) - P1/2 | N=100 | Enrolling by invitation | Sponsor: Healeon Medical Inc | Trial completion date: Aug 2024 ➔ Aug 2025 | Trial primary completion date: Aug 2024 ➔ Aug 2025

Stroma • Trial completion date • Trial primary completion date • Pulmonary Disease • Respiratory Diseases

ADcSVF-IBD: Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease (clinicaltrials.gov) - P1/2 | N=100 | Enrolling by invitation | Sponsor: Healeon Medical Inc | Trial completion date: Mar 2022 ➔ Jun 2025 | Trial primary completion date: Nov 2021 ➔ Aug 2024

Trial completion date • Trial primary completion date • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease

STRAAND: AGA Biocellular Stem/Stromal Hair Regenerative Study (clinicaltrials.gov) - P1/2 | N=60 | Enrolling by invitation | Sponsor: Healeon Medical Inc | Recruiting ➔ Enrolling by invitation

Enrollment status • Alopecia

ADcSVF-COPD: Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders (clinicaltrials.gov) - P1/2 | N=100 | Enrolling by invitation | Sponsor: Healeon Medical Inc | Active, not recruiting ➔ Enrolling by invitation | Trial completion date: Mar 2023 ➔ Aug 2024 | Trial primary completion date: Dec 2022 ➔ Aug 2024

Enrollment open • Trial completion date • Trial primary completion date • Pulmonary Disease • Respiratory Diseases

ADcSVF-CRPS: Adipose Stem/Stromal Cells in RSD, CRPS, Fibromyalgia (clinicaltrials.gov) - P1/2; N=0; Withdrawn; Sponsor: Healeon Medical Inc; N=100 ➔ 0; Enrolling by invitation ➔ Withdrawn

Clinical • Enrollment change • Trial withdrawal • Fibromyalgia • Musculoskeletal Pain • Pain • Rheumatology

cSVF: Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions (clinicaltrials.gov) - P1; N=0; Withdrawn; Sponsor: Healeon Medical Inc; Phase classification: P=N/A ➔ P1; N=100 ➔ 0; Suspended ➔ Withdrawn

Adverse events • Clinical • Clinical data • Enrollment change • Phase classification • Trial withdrawal • CNS Disorders • Immune Modulation • Immunology • Multiple Sclerosis

cSVF: Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions (clinicaltrials.gov) - P=N/A; N=100; Suspended; Sponsor: Healeon Medical Inc; Recruiting ➔ Suspended

Adverse events • Clinical • Clinical data • Trial suspension • CNS Disorders • Immune Modulation • Immunology • Multiple Sclerosis

cSVF-Lung: Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD) (clinicaltrials.gov) - P1; N=50; Suspended; Sponsor: Healeon Medical Inc; Recruiting ➔ Suspended

Trial suspension • Chronic Obstructive Pulmonary Disease • Immunology • Respiratory Diseases

ADcSVF-COPD: Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders (clinicaltrials.gov) - P1/2; N=100; Active, not recruiting; Sponsor: Healeon Medical Inc; Recruiting ➔ Active, not recruiting

Clinical • Enrollment closed • Respiratory Diseases

ADcSVF-IBD: Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease (clinicaltrials.gov) - P1/2; N=100; Enrolling by invitation; Sponsor: Healeon Medical Inc; Recruiting ➔ Enrolling by invitation

Clinical • Enrollment status • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease • CRP